Brand-name semaglutide carries a retail price of approximately $1,300 to $1,900 per month without insurance
This means your doctor may recommend a medicine for a condition it hasnt been approved by the FDA to treat
Wegovy is a once-weekly injection containing the drug semaglutide, approved for weight loss in adults with a BMI over 30, or 27+ with weight-related health issues like high blood pressure or type 2 diabetes
Be alert, because rapid weight loss can contribute to gall bladder problems
554 Astrocyte pathology is a fundamental, if not leading, factor in neuronal death: astrocytes in ALS lose their capability to sustain neurones, to clear glutamate and they some aberrant astrocytic forms are generated, which may cause direct damage
What the Research Shows for Women Over 40 Yes, GLP-1 medications are linked to lean mass loss, but the headline number is misleading